Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov - Ifax

MOSCOW, Dec 7: Russia has granted approval for clinical trials to be held for the Chinese COVID-19 vaccine Ad5-Ncov involving 8,000 volunteers, the Interfax news agency reported on Monday.

Vials labelled "COVID-19 Coronavirus Vaccine" are placed on dry ice in this illustration taken, December 4, 2020. REUTERS/Dado Ruvic/Illustration

Vials labelled "COVID-19 Coronavirus Vaccine" are placed on dry ice in this illustration taken, December 4, 2020. REUTERS/Dado Ruvic/Illustration

By Reuters

MOSCOW, Dec 7: Russia has granted approval for clinical trials to be held for the Chinese COVID-19 vaccine Ad5-Ncov involving 8,000 volunteers, the Interfax news agency reported on Monday.

Ad5-nCoV is a vaccine candidate co-developed by CanSino Biologics and a Chinese military-backed research unit.

Just in

WORLD

German Election: Polls open in Germany

ECONOMY

NRB to mop Rs 30 billion from market for liquidity manag...

SOCIETY

Prohibitory order in Phungling, Pathibhara areas

Republica watch

Nepal's Stock Market Shake-Up: Is a New Exchange N...

Nepal’s 75 years of democratic journey marred by i...

Pathibhara Cable Car Dispute: Why Are Locals Deman...

Subcommittee formed to facilitate Civil Service Bill

The State Affairs and Good Governance Committee under the House of Representatives (HoR) has formed an 11-member sub-committee under the coordination of its member Dilendra Prasad Badu to facilitate t...